Carl Maki to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Carl Maki has written about Drug Resistance, Neoplasm.
Connection Strength
1.005
-
Novel markers of MCL1 inhibitor sensitivity in triple-negative breast cancer cells. J Biol Chem. 2024 Jun; 300(6):107375.
Score: 0.869
-
The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017 Nov 02; 18(11):895-903.
Score: 0.135